Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care

Clinical research site in Salem, Virginia · Blue Ridge Cancer Care - Salem, 1900 Electric Rd, Salem, VA 24153 · (540) 774-8660 · Website

Part of Oncology & Hematology Associates of Southwest Virginia

As of September 2026, 9 paid clinical trials are recruiting at Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care in Salem, Virginia. Active studies at this site cover conditions such as Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma and Carcinoma, Renal Cell. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 11, 2026.

New trial at Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care? We'll email you when one opens.

Recruiting clinical trials at Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care (9)

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

for Urothelial Cancer

133 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07421700·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for Intestinal Neoplasms

200 locations incl. Chandler

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07222800·Phase 3·Recruiting·Listed Oct 2025

Apply to this trial

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

for Carcinoma, Renal Cell

109 locations incl. Phoenix

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07227415·Phase 1, Phase 2·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

for Non-small Cell Carcinoma

223 locations incl. Alabaster

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07144280·Phase 3·Recruiting·Listed Aug 2025

Apply to this trial

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

for Metastatic Castration Sensitive Prostate Cancer (mCSPC)

124 locations incl. Huntsville

Sponsor: Pfizer

Sex: Male·Age: 18+

Code: NCT07028853·Phase 3·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for Colorectal Neoplasms

108 locations incl. Glendale

Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All·Age: 18+

Code: NCT05253651·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer

for Small Cell Lung Cancer (SCLC)

55 locations incl. Fayetteville

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT07226999·Phase 2, Phase 3·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer

for Colorectal Cancer

11 locations incl. Phoenix

Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All·Age: 18+

Code: NCT06948448·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

for Breast Cancer

7 locations incl. Columbia

Sponsor: SCRI Development Innovations, LLC

Sex: All·Age: 18+

Code: NCT05748834·Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Get new-trial alerts for Oncology & Hematology Associates of Southwest Virginia,Inc.DBA Blue Ridge Cancer Care

We'll email you whenever a new clinical trial starts recruiting at this research site in Salem, VA. Unsubscribe anytime.

More research sites in Salem

Salem VA Medical Center, Salem, VA (4 trials)
Foot and Ankle Specialists of the Mid-Atlantic (3 trials)
Oncology & Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care (3 trials)
Salem VA Medical Center (3 trials)
Salem, VA Investigative (3 trials)
Blue Ridge Cancer Care (2 trials)
Blue Ridge Cancer Care (Oncology & Hematology Assoc of SW Virginia, Inc) (1 trial)
Blue Ridge Cancer Care (Oncology & Hematology Associates of Southwest VA) (1 trial)
Blue Ridge Cancer Center (Oncology & Hematology Associates of Southwest VA) (1 trial)
Blue Ridge Surgery Center (1 trial)

Is this your research site?

This page is built from public ClinicalTrials.gov records. If you work here, we can correct it, send you the patients who apply, and build you a free website from your real studies — verify it with your work email, or read what we do for research sites.

Explore more

Paid clinical trials in Salem, VA · Virginia clinical trials